132 related articles for article (PubMed ID: 2563278)
1. Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat.
Graybiel AM; Besson MJ; Weber E
J Neurosci; 1989 Jan; 9(1):326-38. PubMed ID: 2563278
[TBL] [Abstract][Full Text] [Related]
2. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix.
Jimenez-Castellanos J; Graybiel AM
Neuroscience; 1987 Oct; 23(1):223-42. PubMed ID: 3683862
[TBL] [Abstract][Full Text] [Related]
3. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
Beckstead RM
Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
[TBL] [Abstract][Full Text] [Related]
4. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions.
Besson MJ; Graybiel AM; Nastuk MA
Neuroscience; 1988 Jul; 26(1):101-19. PubMed ID: 2901690
[TBL] [Abstract][Full Text] [Related]
5. Striatal substance P cell clusters coincide with the high density terminal zones of the discontinuous nigrostriatal dopaminergic projection system in the cat: a study by combined immunohistochemistry and autoradiographic axon-tracing.
Beckstead RM
Neuroscience; 1987 Feb; 20(2):557-76. PubMed ID: 2438592
[TBL] [Abstract][Full Text] [Related]
6. Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Thibaut F; Hirsch EC; Raisman R; Javoy-Agid F; Agid Y
Neuroscience; 1990; 37(2):387-98. PubMed ID: 1983469
[TBL] [Abstract][Full Text] [Related]
7. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
Savasta M; Dubois A; Benavides J; Scatton B
Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
[TBL] [Abstract][Full Text] [Related]
8. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.
Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831
[TBL] [Abstract][Full Text] [Related]
9. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
Beckstead RM; Wooten GF; Trugman JM
J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
[TBL] [Abstract][Full Text] [Related]
10. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
Coccini T; Manzo L; Costa LG
Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
[TBL] [Abstract][Full Text] [Related]
11. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
[TBL] [Abstract][Full Text] [Related]
12. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
[TBL] [Abstract][Full Text] [Related]
13. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Frohna PA; Rothblat DS; Joyce JN; Schneider JS
Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
15. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
Tam SW; Cook L
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
[TBL] [Abstract][Full Text] [Related]
16. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine.
Chen JF; Qin ZH; Szele F; Bai G; Weiss B
Neuropharmacology; 1991 Sep; 30(9):927-41. PubMed ID: 1833662
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra opiate receptors on basal ganglia efferents.
Ostrowski NL; Pert A
Brain Res Bull; 1995; 38(6):513-23. PubMed ID: 8590072
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra.
Davis MI; Crittenden JR; Feng AY; Kupferschmidt DA; Naydenov A; Stella N; Graybiel AM; Lovinger DM
PLoS One; 2018; 13(2):e0191436. PubMed ID: 29466446
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
Murrin LC; Gale K; Kuhar MJ
Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
